𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preliminary evaluation of iron phytate (inositol hexaphosphate) as a gastrointestinal MR contrast agent

✍ Scribed by Evan C. Unger; Thomas A. Fritz; David Palestrant; Thomas J. Meakem; Per Granstrom; Robert A. Gatenby

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
662 KB
Volume
3
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

A simple, effective, safe, and well‐tolerated contrast agent is needed as a bowel marker for magnetic resonance (MR) imaging. The authors tested a variety of foodstuffs admixed with ferric iron as potential gastrointestinal MR contrast agents. Phytate (inosi‐tol hexaphosphate) more than doubled the relaxiv‐ity of solutions of ferric iron. Because of the improved relaxivity of iron phytate, the concentration of iron could be reduced substantially relative to free ferric iron (eg, ferric chloride or ferric ammonium citrate). Imaging studies were performed in five volunteers to determine the optimal dose of iron phytate and in five additional volunteers to test its effectiveness. A 200 mg/L concentration of ferric iron with phytate functions as an effective gastrointestinal MR contrast agent for T1‐weighted abdominal MR imaging, significantly improving bowel contrast (P <.01). Blood studies after contrast agent administration showed no appreciable increase in serum iron. Compared with standard chelate complexcs that decrease the relaxivity of a given paramagnetic ion, phytate not only decreases the absorption of the iron but increases its relaxivity.

📜 SIMILAR VOLUMES

Phase I clinical evaluation of a new iro
Phase I clinical evaluation of a new iron oxide MR contrast agent
✍ Stuart J. McLachlan; Marie R. Morris; Maria A. Lucas; Ricardo A. Fisco; Michael 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

## Abstract The safety and magnetic resonance (MR) imaging potential of BMS 180549, a new superparamagnetic iron oxide contrast agent, were evaluated in a phase I, open‐label, placebo‐controlled study involving 41 healthy subjects. No clinically significant postdose changes in physical examination

MR imaging of crohn disease: Use of perf
MR imaging of crohn disease: Use of perflubron as a gastrointestinal contrast agent
✍ Clinton M. Anderson; Jeffrey J. Brown; Dennis M. Balfe; Jay P. Heiken; Joseph A. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 846 KB

## Abstract This study was undertaken to evaluate the use of perflubron (perfluorooctylbromide) as an oral contrast agent for magnetic resonance (MR) imaging of patients with Crohn disease. MR examinations were performed before and after perflubron administration in 12 patients with documented Croh

Preliminary evaluation of a polyethylene
Preliminary evaluation of a polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as an intravascular contrast agent for MR angiography
✍ Kofi Adzamli; Richard B. Dorshow; Michael R. Hynes; Debiao Li; Dennis L. Nosco; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 902 KB

## Abstract A blood‐persistent particulate paramagnetic contrast agent has been formulated via size stabilization of manganese‐substituted hydroxylapatite by a polyethylene glycol (PEG) bearing a terminal diphosphonate. At high PEG surface densities (35–40 mol %), particles with mean diameter 8 ± 2

Synthesis and preliminary evaluation of
Synthesis and preliminary evaluation of MP-2269: A novel, nonaromatic small-molecule blood-pool MR contrast agent
✍ Rebecca A. Wallace; Joe P. Haar Jr.; Donald B. Miller; Steven R. Woulfe; John A. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 724 KB

## Abstract A nonaromatic, small‐molecule, gadolinium(3+)‐chelate code named MP‐2269 was synthesized and evaluated in animals as a potential MR contrast agent for blood pool. The ligand of MP‐2269 was prepared by conjugating a lipophilic, albumin‐binding moiety, 4‐pentylbicyclo[2.2.2]octane‐1‐carbo

Evaluation of [Gd(Bz-TTDA)]2– as a poten
Evaluation of [Gd(Bz-TTDA)]2– as a potential contrast agent in MR imaging of the hepatobiliary system: An animal study
✍ Jui-Sheng Hsu; Twei-Shiun Jaw; Gin-Chung Liu; Yun-Ming Wang; Shih-Hsien Chen; Yu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 896 KB

## Abstract ## Purpose To evaluate the potential of a new lipophilic paramagnetic complex [Gd(Bz‐TTDA)]^2–^ [(4s)‐4‐benzyl‐3,6,10‐tri(carboxymethyl)‐3,6,10‐triazadodecandioic acid]^2–^ designed for use as a hepatobiliary MR contrast agent. ## Materials and Methods MR imaging studies for normal a